Log in to save to my catalogue

Investigating the APOE4‐associated heterogeneity of imaging biomarkers across AD diagnostic stages

Investigating the APOE4‐associated heterogeneity of imaging biomarkers across AD diagnostic stages

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11715664

Investigating the APOE4‐associated heterogeneity of imaging biomarkers across AD diagnostic stages

About this item

Full title

Investigating the APOE4‐associated heterogeneity of imaging biomarkers across AD diagnostic stages

Publisher

Hoboken: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2024-12, Vol.20 (S2), p.n/a

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley and Sons Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background
Carriers of the apolipoprotein E ε4 (APOE4) allele are at an increased risk of developing Alzheimer’s disease (AD) and display an earlier age of onset compared to non‐carriers who develop the disease. While researchers have extensively characterized the impact of APOE4 on the susceptibility of AD, little is known about the differences...

Alternative Titles

Full title

Investigating the APOE4‐associated heterogeneity of imaging biomarkers across AD diagnostic stages

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11715664

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11715664

Other Identifiers

ISSN

1552-5260

E-ISSN

1552-5279

DOI

10.1002/alz.087489

How to access this item